BioRegenerative Sciences, Inc. to Present Data on Reduction of Peripheral Pain Using S2RM Technology at Society for Neuroscience Annual Meeting in Washington, DC

San Diego, CA, May 16, 2011 --(PR.com)-- Dr. Greg Maguire and Peter Friedman of BioRegenerative Sciences, Inc. will present data on the reduction of peripheral pain using their stem cell-based S2RM technology at the Society For Neuroscience Annual Meeting in Washington, DC in November, 2011.

Natural healing processes in the human body utilize adult stem cells to home-in and localize damaged tissue, and then release a multitude of molecules to orchestrate a healing cascade of events in the damaged target tissue. The healing cascade induced by adult stem cells is a naturally occurring systems biology-based therapeutic regimen. Mimicking this natural healing process utilized by adult stem cells, BRS has developed topically applied formulations containing the multitude of molecules released by combinations of adult stem cell types, called stem cell released molecules (S2RM), to induce a healing process, and a reduction in pain and inflammation when topically applied to the skin, eyes, and mucosal tissue.

Animal and human testing showed that the molecules induced no irritation and no cytotoxic effects. Laboratory and clinical testing in humans and canine models showed that pain reduction could be achieved rapidly and effectively in all tissues tested, including keratoconjunctival tissue, intact injured skin, ulcerated skin wounds, and mucosa. Rapid and continuous long-term healing of the tissue was associated with a rapid and continuous long-term pain relief. Current studies are underway to explore the mechanisms underlying the healing, anti-inflammatory, and pain relieving properties of the S2RM Technology(TM)

###